Aquatic Capital Management LLC Uni Qure N.V. Transaction History

Aquatic Capital Management LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$4.82 - $6.93 $42,416 - $60,984	8,800 New	8,800 $45,000
Q2 2023 Aug 14, 2023	BUY	$11.12 - $22.2 $120,095 - $239,760	10,800 Added 1800.0%	11,400 $131,000
Q1 2023 May 15, 2023	SELL	$18.7 - $23.07 $441,320 - $544,452	-23,600 Reduced 97.52%	600 $12,000
Q4 2022 Feb 14, 2023	BUY	$18.12 - $27.32 $326,160 - $491,760	18,000 Added 290.32%	24,200 $548,000
Q3 2022 Nov 14, 2022	BUY	$16.98 - $25.54 $105,276 - $158,348	6,200 New	6,200 $116,000
Q2 2022 Aug 15, 2022	SELL	$13.15 - $20.45 $1,315 - $2,045	-100 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$14.54 - $21.5 $1,454 - $2,150	100 New	100 $2,000

142

35.3M

1.54M

389K

Ticker QURE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,729,100
Market Cap $300M
Description
uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy th...

Get notified when there are updates to the investment portfolio of Aquatic Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Aquatic Capital Management LLC with notifications on news.